Verified peer comparison

Karyopharm Therapeutics vs Evolv Technologies Holdings Financial Comparison

Direct answer

Karyopharm Therapeutics and Evolv Technologies Holdings are compared on the same basis.

The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage

Get free Karyopharm Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Karyopharm Therapeutics Revenue
146,067,000 USD
Evolv Technologies Holdings Revenue
145,905,000 USD
Karyopharm Therapeutics Operating income
-90,707,000 USD
Evolv Technologies Holdings Operating income
-44,801,000 USD